# Medication Reconciliation in Oncologic Patients

> **NCT04796142** · NA · COMPLETED · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 100 (actual)

## Conditions studied

- Medication Reconciliation

## Interventions

- **OTHER:** medication reconciliation

## Key facts

- **NCT ID:** NCT04796142
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-12
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04796142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04796142, "Medication Reconciliation in Oncologic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04796142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*